...
首页> 外文期刊>Annals of hematology >Acute renal failure following antithymocyte globulin therapy for aplastic anaemia-report of two cases and review of literature.
【24h】

Acute renal failure following antithymocyte globulin therapy for aplastic anaemia-report of two cases and review of literature.

机译:抗胸腺细胞球蛋白疗法治疗再生障碍性贫血后的急性肾衰竭-2例报告并文献复习。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Imrmmosuppressive therapy with antithymocyte globulin (ATG) with ciclosporine is the standard of care in patients with aplastic anaemia who are not eligible for bone marrow transplantation. ATG is an animal protein and its predominant toxicities include allergic reactions and serum sickness. Acute renal failure attributable to ATG has rarely been described. We report two patients with aplastic anaemia who developed acute renal failure during ATG therapy. Both patients developed oliguric acute renal failure with temporal relation to ATG administration and absence of other etiological factors. One of the patients had complete recovery of renal function with supportive treatment while the other died of sepsis and multi-organ dysfunction.
机译:用抗胸腺细胞球蛋白(ATG)和环孢素进行免疫抑制治疗是再生障碍性贫血,不适合骨髓移植的患者的治疗标准。 ATG是一种动物蛋白,其主要毒性包括过敏反应和血清病。几乎没有描述归因于ATG的急性肾衰竭。我们报道了两名再生障碍性贫血患者在ATG治疗期间发生了急性肾衰竭。两名患者均发生少尿性急性肾功能衰竭,与ATG的给药存在时间关系,并且缺乏其他病因。其中一名患者在支持治疗下肾功能完全恢复,另一名患者死于败血症和多器官功能障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号